Telemedicine Series Part III: Evolving Issues and Trends in Telehealth (On-Demand Webinar)

Date: 04/09/24

Closed captions are available.

Overview: The last webinar in the telemedicine series explores the future of telehealth, focusing on recent legislation, litigation to watch, and other emerging issues.  This webinar covers topics such as data privacy, subscription billing, AI and clinical decision support, remote patient monitoring, and billing for ancillary services.  Speakers provide insight on trends to monitor and best practices for navigating the evolving telehealth regulatory and enforcement landscape.

Learning Objectives: 

  • Gain an understanding of proposed and recent legislation that may impact operations for the telehealth industry., including subscription billing and new state corporate practice of medicine legislation.
  • Gain an understanding of Medicare policy and legislative changes related to remote patient monitoring, including those impacting billing and copays.
  • Gain an understanding of FTC enforcement trends and new state laws governing consumer data privacy that impact the telehealth industry.

Speaker Information:

Nicole A. Liffrig MolifeCounsel, Latham & Watkins LLP

Amy WestergrenAssociate General Counsel, Ro

Nathaniel LacktmanPartner, Foley & Lardner LLP

 

Moderator Information: 

Jennifer KreickPartner, Haynes and Boone, LLP

 

Continuing Education:

CLE: AHLA’s live distance learning webinars are pre-approved for CLE credit in the following states: AL, AR, CA, GA, IL, IN, KS, ME, MI, MS, NC, NE, NJ, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WI, and WV. Please refer to the Distance Learning CLE State Chart on our Continuing Education Page to review the reporting procedure in these and other states.

The maximum number of credits available is 1.80.


CCB: The Compliance Certification Board (CCB)® has approved this event for up to 1.8 NON-LIVE CCB CEUs based on a 50-minute hour. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this event content or of the event sponsor.